DarioHealth (DRIO) Financials: History & Chart

DarioHealth Corp.(DRIO)

Medical - Specialties · New York City, NY

$6.20+0.40 (+6.87%)

Delayed quote: Oct 6, 2026, 10:42 AM EDT

About DarioHealth Corp.

DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management. They also offer 'Dario Musculoskeletal' for preventing and treating common MSK conditions, and 'Dario' behavioral health solutions to improve access to evidence-based care. Their offerings extend to general chronic condition management solutions and DarioEngage, a proprietary care management platform. In terms of hardware, DarioHealth provides smart glucose meters, Bluetooth-connected blood pressure cuffs, digital scales, biofeedback sensor devices, and disposables such as test strip cartridges and lancets for blood glucose monitoring systems. Furthermore, they offer comprehensive diabetes management programs that integrate lifestyle changes, healthy eating guidance, advanced tracking tools, and live coaching. Founded in 2011, the company was formerly known as LabStyle Innovations Corp. before officially changing its name to DarioHealth Corp. in July 2016. Its headquarters are located in New York, New York.

New York City, NY

163 employees

www.dariohealth.com

Healthcare / Medical - Specialties

Sector: Healthcare
Industry: Medical - Specialties
CEO: Erez Raphael

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	21.00M	5.18M	5.58M	5.23M	5.01M	5.37M	6.75M	7.60M	7.42M
Cost of Goods Sold	9.22M	1.99M	2.38M	2.86M	1.99M	1.97M	2.87M	2.11M	2.20M
Gross Profit	11.78M	3.19M	3.20M	2.37M	3.02M	3.40M	3.88M	5.49M	5.22M
Gross Profit Margin	56.1%	61.7%	57.3%	45.3%	60.2%	63.3%	57.5%	72.2%	70.3%
Total Operating Expenses	80.83M	9.67M	10.51M	48.15M	12.50M	-5.80M	-5.53M	-6.18M	-6.81M
Research & Development	10.45M	2.10M	2.38M	2.63M	3.33M	3.72M	4.11M	5.28M	5.45M
Selling, General & Administrative	33.60M	7.57M	8.12M	8.73M	9.17M	8.44M	9.18M	9.86M	10.46M
Operating Income (EBIT)	-69.05M	-6.48M	-7.31M	-45.78M	-9.48M	9.20M	9.41M	11.67M	12.03M
Operating Margin	-328.8%	-125.1%	-130.9%	-875.2%	-189.4%	171.4%	139.4%	153.4%	162.1%
Income Before Tax (EBT)	68.14M	-7.60M	-8.19M	94.40M	-10.47M	-12.99M	-9.21M	-9.48M	-12.34M
Interest Income	577K	N/A	160K	242K	175K	237K	289K	161K	226K
Interest Expense	5.59M	1.12M	1.17M	2.11M	1.19M	31K	34K	22K	29K
Other Income/Expense	137.19M	-1.12M	-883K	140.18M	-982K	-22.19M	-18.61M	-21.14M	-24.37M
Net Income	67.78M	-7.92M	-8.25M	86.03M	-2.08M	-12.99M	-9.23M	-9.63M	-12.33M
Income Tax Expense	363K	328K	57K	-22K	0.00	0.00	22K	155K	-13K
Net Profit Margin	322.8%	-153.1%	-147.7%	1644.6%	-41.5%	-241.9%	-136.7%	-126.7%	-166.1%
EBITDA	-67.24M	-5.96M	-6.79M	-45.55M	-8.94M	10.00M	10.66M	14.22M	13.74M
EBITDA Margin	-320.2%	-115.2%	-121.5%	-870.8%	-178.5%	186.3%	158.0%	187.1%	185.0%
Depreciation & Amortization	1.81M	515K	524K	227K	547K	802K	1.26M	2.56M	1.71M
EPS Basic	0.69	-0.85	-0.17	1.90	-0.19	-0.20	-0.31	-0.26	-0.25
EPS Diluted	0.69	-0.85	-0.17	1.90	-0.19	-0.20	-0.31	-0.26	-0.25
Weighted Average Basic Shares	9.34M	9.34M	49.63M	49.63M	49.63M	49.63M	45.02M	40.42M	40.42M
Weighted Average Diluted Shares	9.34M	9.34M	49.63M	49.63M	49.63M	49.63M	45.02M	40.42M	40.42M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	22.36M	27.04M	20.35M	27.66M	20.51M	7.58M	7.56M	7.39M
Cost of Goods Sold	9.69M	13.77M	14.37M	18.00M	12.44M	5.06M	4.96M	5.63M
Gross Profit	12.66M	13.27M	5.98M	9.65M	8.07M	2.51M	2.60M	1.76M
Gross Profit Margin	56.6%	49.1%	29.4%	34.9%	39.3%	33.2%	34.4%	23.9%
Total Operating Expenses	49.32M	71.01M	62.17M	66.47M	84.56M	32.42M	20.30M	19.45M
Research & Development	13.79M	24.18M	20.25M	19.65M	17.22M	4.43M	3.69M	3.68M
Selling, General & Administrative	35.53M	46.83M	41.80M	46.82M	62.36M	27.98M	16.61M	15.78M
Operating Income (EBIT)	-36.66M	-57.74M	-56.19M	-56.81M	-76.49M	-29.90M	-17.70M	-17.69M
Operating Margin	-163.9%	-213.6%	-276.1%	-205.4%	-372.9%	-394.7%	-234.2%	-239.2%
Income Before Tax (EBT)	-41.61M	-44.60M	-59.36M	-62.19M	-76.73M	-29.45M	-17.74M	-17.80M
Interest Income	943K	1.12M	1.87M	506K	44K	61K	16K	N/A
Interest Expense	3.36M	96K	645K	2.68M	84K	49K	27K	18K
Other Income/Expense	-4.95M	13.14M	-3.17M	-5.38M	-235K	458K	-31K	-115K
Net Income	-41.71M	-42.75M	-59.43M	-62.19M	-76.76M	-29.45M	-17.74M	-17.80M
Income Tax Expense	105K	-1.85M	64K	4K	32K	0.00	0.00	-115K
Net Profit Margin	-186.6%	-158.1%	-292.0%	-224.9%	-374.2%	-388.7%	-234.6%	-240.8%
EBITDA	-33.10M	-50.32M	-51.20M	-52.09M	-72.04M	-29.71M	-17.52M	-17.48M
EBITDA Margin	-148.0%	-186.1%	-251.6%	-188.4%	-351.2%	-392.2%	-231.8%	-236.4%
Depreciation & Amortization	3.56M	7.43M	4.99M	4.72M	4.46M	190K	183K	207K
EPS Basic	-0.81	-0.74	-1.93	-2.63	-4.63	-5.55	-7.84	-15.21
EPS Diluted	-0.81	-0.74	-1.93	-2.63	-4.63	-5.55	-7.84	-15.21
Weighted Average Basic Shares	49.63M	40.42M	28.37M	23.64M	16.59M	5.96M	2.27M	1.17M
Weighted Average Diluted Shares	49.63M	40.42M	28.37M	23.64M	16.59M	5.96M	2.27M	1.17M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.